1. Home
  2. CALC
  3. CALC News

Latest CalciMedica Inc. (CALC) News on June 27, 2025

CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure
CALC

PR Newswire

2 days ago

CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure

CalciMedica Insiders Added US$1.05m Of Stock To Their Holdings
CALC

Simply Wall St.

14 days ago

CalciMedica Insiders Added US$1.05m Of Stock To Their Holdings

CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting
CALC

PR Newswire

15 days ago

CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting

CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
CALC

PR Newswire

a month ago

CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Announces Presentations at Upcoming Medical Meetings
CALC

PR Newswire

2 months ago

CalciMedica Announces Presentations at Upcoming Medical Meetings

CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference
CALC

PR Newswire

3 months ago

CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates
CALC

PR Newswire

3 months ago

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Secures Credit Facility for Up to $32.5 Million
CALC

PR Newswire

4 months ago

CalciMedica Secures Credit Facility for Up to $32.5 Million

CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference
CALC

PR Newswire

4 months ago

CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference

CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference
CALC

PR Newswire

4 months ago

CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference

CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
CALC

PR Newswire

5 months ago

CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors
CALC

PR Newswire

5 months ago

CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors

CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference
CALC

PR Newswire

7 months ago

CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference

CalciMedica Announces Presentations at Upcoming Medical Meetings
CALC

PR Newswire

7 months ago

CalciMedica Announces Presentations at Upcoming Medical Meetings

CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
CALC

PR Newswire

7 months ago

CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer
CALC

PR Newswire

8 months ago

CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer

CALC

Argus Research

8 months ago

Daily – Vickers Top Buyers & Sellers for 11/06/2024

CalciMedica Announces Pricing of Public Offering of Common Stock
CALC

PR Newswire

8 months ago

CalciMedica Announces Pricing of Public Offering of Common Stock

CalciMedica Announces Proposed Public Offering of Common Stock
CALC

PR Newswire

8 months ago

CalciMedica Announces Proposed Public Offering of Common Stock

CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting
CALC

PR Newswire

8 months ago

CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting

CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
CALC

PR Newswire

8 months ago

CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting
CALC

PR Newswire

8 months ago

CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting

CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference
CALC

PR Newswire

10 months ago

CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference

CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
CALC

PR Newswire

10 months ago

CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI)
CALC

PR Newswire

a year ago

CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI)

CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences
CALC

PR Newswire

a year ago

CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences

CALC

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 07/03/2024

CalciMedica Set to Join Russell Microcap® Index
CALC

PR Newswire

a year ago

CalciMedica Set to Join Russell Microcap® Index

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
CALC

PR Newswire

a year ago

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
CALC

PR Newswire

a year ago

CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
CALC

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller
CALC

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up
CALC

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge
CALC

Bloomberg

a year ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally
CALC

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
CALC

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
CALC

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
CALC

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
CALC

PR Newswire

a year ago

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024
CALC

PR Newswire

a year ago

CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024

CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis
CALC

PR Newswire

a year ago

CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis

CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates
CALC

PR Newswire

a year ago

CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference
CALC

PR Newswire

a year ago

CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference

CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference
CALC

PR Newswire

a year ago

CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference

CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for the Treatment of Severe Acute Kidney Injury
CALC

PR Newswire

a year ago

CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for the Treatment of Severe Acute Kidney Injury

CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
CALC

PR Newswire

a year ago

CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Investors in LightPath Technologies (NASDAQ:LPTH) have unfortunately lost 66% over the last three years
CALC

Simply Wall St.

a year ago

Investors in LightPath Technologies (NASDAQ:LPTH) have unfortunately lost 66% over the last three years

LightPath Technologies Schedules Fiscal 2024 Second Quarter Financial Results Conference Call for February 8, 2024
CALC

ACCESSWIRE

a year ago

LightPath Technologies Schedules Fiscal 2024 Second Quarter Financial Results Conference Call for February 8, 2024

Investors in Sensus Healthcare (NASDAQ:SRTS) from a year ago are still down 60%, even after 24% gain this past week
CALC

Simply Wall St.

a year ago

Investors in Sensus Healthcare (NASDAQ:SRTS) from a year ago are still down 60%, even after 24% gain this past week

Velo3D Announces Key Strategic Priorities for Growth in 2024
CALC

Business Wire

a year ago

Velo3D Announces Key Strategic Priorities for Growth in 2024

Advanced Emissions Solutions to Rebrand as Arq, Inc.
CALC

GlobeNewswire

a year ago

Advanced Emissions Solutions to Rebrand as Arq, Inc.

CalciMedica Announces Private Placement of up to Approximately $55 Million
CALC

PR Newswire

a year ago

CalciMedica Announces Private Placement of up to Approximately $55 Million

Sidoti Events, LLC's Virtual January Micro-Cap Conference
CALC

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Tilly's (TLYS) Posts Soft Holiday Sales, Comps Decline 9%
CALC

Zacks

a year ago

Tilly's (TLYS) Posts Soft Holiday Sales, Comps Decline 9%

INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)
CALC

PR Newswire

a year ago

INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)

PLBY Group to Participate in the 2024 ICR Conference
CALC

GlobeNewswire

a year ago

PLBY Group to Participate in the 2024 ICR Conference

The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics
CALC

Zacks

2 years ago

The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics

Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia
CALC

GlobeNewswire

2 years ago

Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia

Insiders own 22% of Affinity Bancshares, Inc. (NASDAQ:AFBI) shares but retail investors control 53% of the company
CALC

Simply Wall St.

2 years ago

Insiders own 22% of Affinity Bancshares, Inc. (NASDAQ:AFBI) shares but retail investors control 53% of the company

CalciMedica Collaborator St. Jude Children's Research Hospital Presents Data from Initial Cohort of CRSPA Study at 65th Annual ASH Meeting & Exposition
CALC

PR Newswire

2 years ago

CalciMedica Collaborator St. Jude Children's Research Hospital Presents Data from Initial Cohort of CRSPA Study at 65th Annual ASH Meeting & Exposition

Poseida Therapeutics Presents Positive Early Results from its Phase 1 Trial of Allogeneic CAR-T P-BCMA-ALLO1 in Relapsed-Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting
CALC

PR Newswire

2 years ago

Poseida Therapeutics Presents Positive Early Results from its Phase 1 Trial of Allogeneic CAR-T P-BCMA-ALLO1 in Relapsed-Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting

POET Technologies Earns High Praise from Industry Expert in New e-Book
CALC

GlobeNewswire

2 years ago

POET Technologies Earns High Praise from Industry Expert in New e-Book

Cumulus Media’s Westwood One Presents Exclusive National Audio Coverage of the 124th Army-Navy Football Game
CALC

GlobeNewswire

2 years ago

Cumulus Media’s Westwood One Presents Exclusive National Audio Coverage of the 124th Army-Navy Football Game

POET Technologies Issues Letter to Shareholders
CALC

GlobeNewswire

2 years ago

POET Technologies Issues Letter to Shareholders

POET Technologies Announces Closing of US$1.6 Million Underwritten Public Offering of Common Shares and Warrants
CALC

GlobeNewswire

2 years ago

POET Technologies Announces Closing of US$1.6 Million Underwritten Public Offering of Common Shares and Warrants

Dyadic Attends Investor Events in December
CALC

GlobeNewswire

2 years ago

Dyadic Attends Investor Events in December

BioAtla to Participate in the JMP Securities Hematology and Oncology Summit
CALC

GlobeNewswire

2 years ago

BioAtla to Participate in the JMP Securities Hematology and Oncology Summit

CALC

Business Wire

2 years ago

KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference

CALC

Business Wire

2 years ago

KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023

ASP Isotopes Inc. Enters Into Memorandum of Understanding (MOU) With Second US-based Small Modular Reactor (SMR) Company To Supply High Assay Low Enriched Uranium (HALEU)
CALC

GlobeNewswire

2 years ago

ASP Isotopes Inc. Enters Into Memorandum of Understanding (MOU) With Second US-based Small Modular Reactor (SMR) Company To Supply High Assay Low Enriched Uranium (HALEU)

13 Stocks Insiders are Buying Now
CALC

Insider Monkey

2 years ago

13 Stocks Insiders are Buying Now

3 Medical Services Stocks to Buy as Industry Trends Improve
CALC

Zacks

2 years ago

3 Medical Services Stocks to Buy as Industry Trends Improve

Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
CALC

GlobeNewswire

2 years ago

Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

HIGHLIGHTS: Join CEO of Live Ventures in Fireside Chat
CALC

IPO-Edge.com

2 years ago

HIGHLIGHTS: Join CEO of Live Ventures in Fireside Chat

NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
CALC

GlobeNewswire

2 years ago

NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements

Texas Community Bancshares, Inc. Authorizes New Stock Repurchase Program
CALC

PR Newswire

2 years ago

Texas Community Bancshares, Inc. Authorizes New Stock Repurchase Program

KORU Medical Systems, Inc. (NASDAQ:KRMD) Q3 2023 Earnings Call Transcript
CALC

Insider Monkey

2 years ago

KORU Medical Systems, Inc. (NASDAQ:KRMD) Q3 2023 Earnings Call Transcript

CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
CALC

PR Newswire

2 years ago

CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

Adams Resources & Energy Inc (AE) Reports Mixed Q3 Results Amidst Market Challenges
CALC

GuruFocus.com

2 years ago

Adams Resources & Energy Inc (AE) Reports Mixed Q3 Results Amidst Market Challenges

CALC

Associated Press Finance

2 years ago

Adams Resources: Q3 Earnings Snapshot

ADAMS RESOURCES & ENERGY, INC. ANNOUNCES THIRD QUARTER 2023 RESULTS AND DECLARES QUARTERLY DIVIDEND
CALC

PR Newswire

2 years ago

ADAMS RESOURCES & ENERGY, INC. ANNOUNCES THIRD QUARTER 2023 RESULTS AND DECLARES QUARTERLY DIVIDEND

Ikena Oncology to Present at Multiple November 2023 Investor Conferences
CALC

GlobeNewswire

2 years ago

Ikena Oncology to Present at Multiple November 2023 Investor Conferences

Mastech Digital, Inc. (AMEX:MHH) Q3 2023 Earnings Call Transcript
CALC

Insider Monkey

2 years ago

Mastech Digital, Inc. (AMEX:MHH) Q3 2023 Earnings Call Transcript

CALC

GuruFocus.com

2 years ago

Clipper Realty Inc (CLPR) Reports Q3 2023 Earnings: Record Revenues and NOI Amidst Net Loss

HF Foods to Report Third Quarter 2023 Results on November 9, 2023
CALC

GlobeNewswire

2 years ago

HF Foods to Report Third Quarter 2023 Results on November 9, 2023

Clipper Realty Inc. Announces Third Quarter 2023 Results
CALC

Business Wire

2 years ago

Clipper Realty Inc. Announces Third Quarter 2023 Results

Share on Social Networks: